WO2008132846A1 - 三環性ヘテロアリール化合物 - Google Patents

三環性ヘテロアリール化合物 Download PDF

Info

Publication number
WO2008132846A1
WO2008132846A1 PCT/JP2008/001073 JP2008001073W WO2008132846A1 WO 2008132846 A1 WO2008132846 A1 WO 2008132846A1 JP 2008001073 W JP2008001073 W JP 2008001073W WO 2008132846 A1 WO2008132846 A1 WO 2008132846A1
Authority
WO
WIPO (PCT)
Prior art keywords
chloro
benzoxazepin
ethoxyphenyl
triazolo
trifluoromethyl
Prior art date
Application number
PCT/JP2008/001073
Other languages
English (en)
French (fr)
Inventor
Kazuyuki Sugita
Masami Ohtsuka
Hitoshi Oki
Noriyasu Haginoya
Masanori Ichikawa
Masahiro Ota
Yoshihiro Shibata
Original Assignee
Daiichi Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited
Publication of WO2008132846A1 publication Critical patent/WO2008132846A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

　スクアレン合成酵素阻害作用、コレステロール合成阻害作用を示し、ヒトを含む哺乳動物のための高コレステロール血症、高トリグリセライド血症、低ＨＤＬ血症等の高脂血症及び／または動脈硬化症の予防及び／または治療薬等の医薬として有用な化合物の提供。 （１）２－［（４Ｒ，６Ｓ）－８－クロロ－６－（２－クロロ－３－エトキシフェニル）－１－（トリフルオロメチル）－４Ｈ，６Ｈ－［１，２，４］トリアゾロ［４，３－ａ］［４，１］ベンゾオキサゼピン－４－イル］アセティック　アシッド （２）２－（１－｛２－［（４Ｒ，６Ｓ）－８－クロロ－６－（２－クロロ－３－エトキシフェニル）－１－（トリフルオロメチル）－４Ｈ，６Ｈ－［１，２，４］トリアゾロ［４，３－ａ］［４，１］ベンゾオキサゼピン－４－イル］アセチル｝－４－ピペリジニル）アセティック　アシッド等の特定化合物。
PCT/JP2008/001073 2007-04-25 2008-04-24 三環性ヘテロアリール化合物 WO2008132846A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007115164A JP2010150142A (ja) 2007-04-25 2007-04-25 三環性ヘテロアリール化合物
JP2007-115164 2007-04-25

Publications (1)

Publication Number Publication Date
WO2008132846A1 true WO2008132846A1 (ja) 2008-11-06

Family

ID=39925317

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/001073 WO2008132846A1 (ja) 2007-04-25 2008-04-24 三環性ヘテロアリール化合物

Country Status (3)

Country Link
JP (1) JP2010150142A (ja)
TW (1) TW200846007A (ja)
WO (1) WO2008132846A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010041726A1 (ja) * 2008-10-10 2010-04-15 第一三共株式会社 置換三環性ヘテロアリール化合物
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505135B2 (ja) 2010-06-30 2014-05-28 ソニー株式会社 画像処理装置、画像処理方法、および、プログラム

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187684A (ja) * 1984-10-01 1986-05-06 ベーリンガー　インゲルハイム　コマンデイツト　ゲゼルシヤフト ジアゼピン含有医薬組成物
JPS62240686A (ja) * 1986-04-01 1987-10-21 ベ−リンガ−　インゲルハイム　コマンデイツト　ゲゼルシヤフト １、４−ジアゼピン化合物
WO1993007129A1 (en) * 1991-10-11 1993-04-15 Yoshitomi Pharmaceutical Industries, Ltd. Remedy for osteoporosis and diazepine compound
WO2005012272A1 (ja) * 2003-08-01 2005-02-10 Takeda Pharmaceutical Company Limited ベンズオキサゼピン系化合物
WO2005068472A1 (de) * 2004-01-14 2005-07-28 Bayer Healthcare Ag Tricyclische benzazepin-derivate als squalene synthase inhibitoren zur behandlung von kardiovaskulären erkrankungen
WO2007055093A1 (ja) * 2005-10-21 2007-05-18 Daiichi Sankyo Company, Limited 三環性化合物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187684A (ja) * 1984-10-01 1986-05-06 ベーリンガー　インゲルハイム　コマンデイツト　ゲゼルシヤフト ジアゼピン含有医薬組成物
JPS62240686A (ja) * 1986-04-01 1987-10-21 ベ−リンガ−　インゲルハイム　コマンデイツト　ゲゼルシヤフト １、４−ジアゼピン化合物
WO1993007129A1 (en) * 1991-10-11 1993-04-15 Yoshitomi Pharmaceutical Industries, Ltd. Remedy for osteoporosis and diazepine compound
WO2005012272A1 (ja) * 2003-08-01 2005-02-10 Takeda Pharmaceutical Company Limited ベンズオキサゼピン系化合物
WO2005068472A1 (de) * 2004-01-14 2005-07-28 Bayer Healthcare Ag Tricyclische benzazepin-derivate als squalene synthase inhibitoren zur behandlung von kardiovaskulären erkrankungen
WO2007055093A1 (ja) * 2005-10-21 2007-05-18 Daiichi Sankyo Company, Limited 三環性化合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010041726A1 (ja) * 2008-10-10 2010-04-15 第一三共株式会社 置換三環性ヘテロアリール化合物
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Also Published As

Publication number Publication date
JP2010150142A (ja) 2010-07-08
TW200846007A (en) 2008-12-01

Similar Documents

Publication Publication Date Title
EP2086945A4 (en) NOVEL PROCESS FOR THE PRODUCTION OF STATINES AND THEIR PHARMACEUTICAL ACCEPTIC SALTS
EP1773768B8 (en) Pyrrole derivatives as pharmaceutical agents
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
AU2003901057A0 (en) Intra-abdominal urinary catheter pressure monitor
EP2054416B8 (en) Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
WO2004094596A8 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
IL180546A0 (en) Novel piperidine derivative for the treatment of depression
WO2008006795A3 (en) Indole compounds
IL181827A0 (en) Donepezil salts suitable for the preparation of pharmaceutical compositions
WO2009060952A1 (ja) 新規製剤
WO2008132846A1 (ja) 三環性ヘテロアリール化合物
EP2392335A3 (en) Use of 24-norUDCA
AU2001236713A1 (en) Methods for treatment of lysosomal storage diseases
AU2003233966A1 (en) Analogous compounds of strobilurines and their use as acaricides and insecticides
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
WO2008061671A3 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
AU4937699A (en) Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing
IL195062A0 (en) Process for the preparation of solid sterile active pharmaceutical ingredient
GB0513182D0 (en) Use of ethyl lactate as an excipient for pharmaceutical compositons
WO2006002203A8 (en) Methods and compositions for the treatment of polycystic diseases
EP1779156A4 (en) Uv barrier formulation for polyesters
AU2003272198A1 (en) Storage of blood
AU2008339005A8 (en) 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of Alzheimer's disease
AU2002356423A1 (en) Process for the preparation of amorphous atorvastatin calcium

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751598

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08751598

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP